United States Small Molecule CDMO Market was valued at USD 6.2 Billion in 2022 and is projected to reach USD 10.9 Billion by 2030, growing at a CAGR of 8.3% from 2024 to 2030.
The US Small Molecule CDMO Market is a key player in the pharmaceutical and biotechnology industries, offering specialized services for the development and manufacturing of small molecule drugs. As pharmaceutical companies increasingly focus on cost-efficient solutions, contract development and manufacturing organizations (CDMOs) have become essential partners. These companies provide a wide range of services, including drug development, formulation, scale-up production, and commercialization. Small molecule drugs, which are typically synthetic compounds, play a vital role in the treatment of various diseases such as cancer, cardiovascular disorders, and infectious diseases.
The demand for small molecule CDMO services is driven by the ongoing need for innovative drug development, especially in the treatment of complex conditions. Pharmaceutical companies are outsourcing the production of small molecule drugs to CDMOs to minimize costs, speed up the time to market, and focus on their core competencies. In fact, the global small molecule CDMO market is expected to grow significantly due to the increasing number of biologics and generics being developed in the pharmaceutical space. This growth is also supported by a surge in investment in biotechnology research and development.
From the industry perspective, small molecule CDMO services must meet a set of stringent requirements. These include compliance with regulatory standards, such as Good Manufacturing Practice (GMP), ensuring high-quality production with minimal risks of contamination. CDMOs must also offer expertise in drug formulation and process development, enabling them to handle complex molecules while maintaining cost-effectiveness. Additionally, industry players are seeking CDMOs that can scale up from small batch production to large-scale manufacturing efficiently.
Moreover, the requirements from industries are expanding to include advanced technologies, such as continuous manufacturing and automated production processes, to enhance productivity and lower costs. As competition within the US Small Molecule CDMO Market intensifies, companies that can deliver high-quality, cost-efficient services with a quick turnaround time will be in the best position to capture market share. The demand for these services continues to be fueled by the increasing need for custom-made solutions in the production of small molecule drugs.
Get an In-Depth Research Analysis of the US Small Molecule CDMO Market Size And Forecast [2025-2032]
Â
Lonza
Catalent
Thermo Fisher
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Jiangsu Sinopep
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Jubilant Pharmova
Consort Medical
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Small Molecule CDMO Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Small Molecule CDMO Market
Oncology
Cardiovascular
CNS Disorders
Infectious Diseases
Metabolic Disorders
Small Molecule Drugs
Generic Small Molecules
Innovative Small Molecules
Custom Synthesis
Process Development
Scale-Up Production
Analytical Services
Pharmaceutical Companies
Biotechnology Firms
Academic Research Institutions
Contract Research Organizations (CROs)
Full-Service CDMO
Specialized CDMO
Virtual Manufacturers
Collaborative Partners
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Small Molecule CDMO Market Research Analysis
1. Introduction of the US Small Molecule CDMO Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Small Molecule CDMO Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Small Molecule CDMO Market, By Type
6. US Small Molecule CDMO Market, By Application
7. US Small Molecule CDMO Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Small Molecule CDMO Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/